Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

7 Aug 2012 16:57

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the "Company") announces that following the purchase of ordinary 25p shares ("Shares") on 3 August 2012 under the terms of the Tate & Lyle PLC Dividend Reinvestment Plan ("DRIP"), the Company was informed that the following directors of the Company have acquired interests in additional Shares at a purchase price of 676.99 pence per share:

Name No. of Shares acquired Date of notification to the Company Total No. of Shares held following purchase
Sir Peter Gershon (Chairman) 1,763 07/08/2012 69,499
Javed Ahmed (Chief Executive) 26,419 06/08/2012 1,041,279
Tim Lodge (Chief Financial Officer) 1,347 06/08/2012 53,070
Evert Henkes 28 06/08/2012 1,136
Robert Walker 296 07/08/2012 11,678

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FSA's Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

7 August 2012

Copyright Business Wire 2012

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.